Feng Guo1, Li Zhang2, Yuzhen Yu3

  • 1Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.

EBioMedicine
|February 28, 2024
PubMed
概括

一种新发现的增强剂调节人类肺细胞中的HHIP基因表达,影响慢性阻塞性肺病 (COPD) 风险. 这一发现揭示了HHIP的存在.